Featured

Status

All Statuses
  • Not yet recruiting1

Health Topics

Any Category
Diseases
Immune System Diseases
Immunoproliferative Disorders
Lymphoproliferative Disorders
Lymphoma
Lymphoma, Non-Hodgkin
Lymphoma, B-Cell
Clear Filters

Search Clinical Trials

1 Result
Not Yet Recruiting
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
This is a dose escalation study. This means that at the beginning, patients will be started on the lowest dose (1 of 4 different levels) of C7R.CD30.CAR-EBVST cells. Once the …
Baylor Role: Lead Sponsor